Institutional investors purchased a net $4.8 million shares of RMD during the quarter ended June 2016 and now own 65.03% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LEGAL & GENERAL INVESTMENT MANAG... Bought 376.8 Thousand shares of ResMed Inc
BMO ASSET MANAGEMENT, INC. Bought 100.2 Thousand shares of ResMed Inc
PRINCIPAL MANAGEMENT CORP. Bought 11.0 Thousand shares of ResMed Inc